Glycogen Storage Disease Type III clinical trials at UC Irvine
2 research studies open to eligible people
Showing trials for
Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)
open to eligible people ages 18 years and up
The primary objective of the study is to evaluate the safety of UX053 in adults with Glycogen Storage Disease Type III (GSD III).
Orange, California and other locations
Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
open to eligible people ages 5-65
The primary objective of this study is to evaluate potential biomarkers of GSD III.
Irvine, California and other locations
Last updated: